Transforming Diabetes Care: The Expanding Role of DPP-4 Inhibitors in Cardiovascular and Renal Protection
Francisco Epelde · 2024
Read Transforming Diabetes Care: The Expanding Role of DPP-4 Inhibitors in Cardiovascular and Renal Protection by Francisco Epelde (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11596878.txt.
Description
ting to high rates of morbidity and mortality. Dipeptidyl peptidase-4 (DPP-4) inhibitors, known primarily for their glucose-lowering effects, have become integral in the therapeutic regimen for T2DM due to their low risk of hypoglycemia and weight neutrality, making them particularly suitable for a diverse patient population [3,4].
Catalog record
| CREATOR | Francisco Epelde |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |